Healthcare Digital July 8, 2024
Sean Ashcroft

Nestlé Health Science launches nutrition initiative to counteract side effects of weight-loss drugs, including hollowed-out ‘Ozempic Face’

The surge in sales of weight loss drugs – particularly in the US – is having a ripple effect on other markets, both in the foods and healthcare sectors.

Weight loss drugs are believed to be behind a fall in demand for the kind of foods associated with weight gain. Analysts at Morgan Stanley estimate that US consumption of fizzy soft drinks, baked goods and salty snacks could fall by up to 3% by 2035.

These drugs are also reshaping the healthcare industry, as people seek solutions to some of the unwanted cosmetic effects of rapid weight loss.

One such effect is so-called...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Patient / Consumer, Pharma / Biotech, Provider, Retailer
Walmart's '24 healthcare exit: 10 notes
What big retailers did in healthcare in 2024
How Trauma-Informed Design Principles Can Be Health-Ful for All of Us – Learning from IKEA
Walmart health and wellness leader to exit role
Instacart inks another healthcare partnership

Share This Article